Diagnostic criteria for vascular cognitive disorders: A VASCOG statement

Alzheimer Disease and Associated Disorders

Volumn 28, Issue 3, 2014, Pages 206-218

  Sachdev, Perminder ^a,b   Kalaria, Raj ^c   O'Brien, John ^d   Skoog, Ingmar ^e   Alladi, Suvarna ^f   Black, Sandra E ^g   Blacker, Deborah ⁱ   Blazer, Dan G ^j   Chen, Christopher ^k   Chui, Helena ^l   Ganguli, Mary ^m   Jellinger, Kurt ⁿ   Jeste, Dilip V ^o   Pasquier, Florence ^p   Paulsen, Jane ^q   Prins, Niels ^r   Rockwood, Kenneth ^h   Roman, Gustavo ^s   Scheltens, Philip ^r  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^g UNIVERSITY OF TORONTO   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j DUKE UNIVERSITY MEDICAL CENTER   (United States)

^k NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^m UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

ⁿ INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p UNIV LILLE   (France)

^q UNIVERSITY OF IOWA   (United States)

^r VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^s HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

more..

Author keywords

cerebrovascular disease; diagnostic criteria; multi infarct dementia; poststroke dementia; subcortical dementia; vascular cognitive disorder; vascular cognitive impairment; vascular dementia

Indexed keywords

ALBUMIN; AMYLOID BETA PROTEIN[1-42]; MATRIX METALLOPROTEINASE; SULFATIDE; TAU PROTEIN;

ALZHEIMER DISEASE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; BEHAVIOR DISORDER; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DSM-5; DSM-IV; EVIDENCE BASED PRACTICE; HUMAN; ICD-10; LACUNAR STROKE; MEDICAL SOCIETY; MENTAL DISEASE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SYMPOSIUM; VASCULAR COGNITIVE DISORDER; COGNITION DISORDERS; DEMENTIA, VASCULAR;

COGNITION DISORDERS; DEMENTIA, VASCULAR; HUMANS;

EID: 84907140872     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000034     Document Type: Article

References (84)

1. Kraepelin E. Psychiatrie: Ein Lehrbuch für Studierende und Ä rtze. Leipzig: Johann Ambrosius Barth; 1910.
2. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968; 114:797-811.
3. Hachinski VC, Lassen NA, Marshall J. Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet. 1974; 2:207-210.
4. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43: 250-260.
5. Chui HC, Victoroff JI, Margolin D, et al. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 1992;42:473-480.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.
7. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: World Health Organization; 1993.
8. Hachinski VC, Iliff LD, Zilkha E, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632-637.
9. Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000;59:23-30.
10. Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards. Stroke. 2006;37:2220-2241.
11. Sachdev P. Is it time to retire the term "dementia"? J Neuropsychiatry Clin Neurosci. 2000;12:276-279.
12. Hachinski VC, Bowler JV. Vascular dementia. Neurology. 1993;43:2159-2160.
13. O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol. 2003;2:89-98.
14. Looi JCL, Sachdev PS. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 1999;53:670-678.
15. Wetterling T, Kanitz RD, Borgis KJ. Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). Stroke. 1996;27:30-36.
16. Pohjasvaara T, Erkinjuntti T, Vataja R, et al. Dementia three months after stroke. Baseline frequency and effect of different definitions of dementia in the Helsinki Stroke Aging Memory Study (SAM) cohort. Stroke. 1997;28:785-792.
17. Jellinger KA. Morphologic diagnosis of "vascular dementia"-a critical update. J Neurol Sci. 2008;270:1-12.
18. Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S10-S15.
19. Snowdon DA, Greiner LH, Mortimer JA, et al. Brain infarction and the clinical expression of Alzheimer's disease: The nun study. JAMA. 1997;227:813-817.
20. Skoog I. Vascular aspects in Alzheimer's disease. J Neural Transm Suppl. 2000;59:37-43.
21. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263-269.
22. Albert MS, Dekosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270-279.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edition (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.
24. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713.
25. Sachdev P. Vascular cognitive disorder. Int J Geriatr Psychiatry. 1999;14:402-403.
26. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256:240-246.
27. World Health Organization (WHO). International Classification of Functioning, Disability and Health (ICF), 2001. Available at: http://www.who.int/classification/icf/en/. Accessed May 20, 2011.
28. Kalaria RN, Kenny RA, Ballard CG, et al. Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci. 2004;226:75-80.
29. Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol. 2010;9:895-905.
30. Kimura S, Saito H, Minami M, et al. Pathogenesis of vascular dementia in stroke-prone spontaneously hypertensive rats. Toxicology. 2000;153:167-178.
31. Strachan MW, Reynolds RM, Marioni RE, et al. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011;7:108-114.
32. Sachdev PS, Valenzuela MJ, Brodaty H, et al. Homocysteine as a risk factor for cognitive impairment in stroke patients. Dement Geriatr Cogn Disord. 2003;15:155-162.
33. Román GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006;27:1769-1785.
34. Liman TG, Heuschmann PU, Endres M, et al. Changes in cognitive function over 3 years after first-ever stroke and predictors of cognitive impairment and long-term cognitive stability: The Erlangen Stroke Project. Dement Geriatr Cogn Disord. 2011;31:291-299.
35. Tomimoto H, Ohtani R, Shibata M, et al. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement Geriatr Cogn Disord. 2005;19:282-288.
36. Román GC, Erkinjuntti T, Wallin A, et al. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436.
37. Tullberg M, Fletcher E, DeCarli C, et al. White matter lesions impair frontal lobe function regardless of their location. Neurology. 2004;63:246-253.
38. Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838.
39. Kuller LH. Epidemiology of stroke. In: Schoenberg BS, ed. Neurological Epidemiology: Principles and Clinical Applications. New York: Raven Press; 1978:281-311.
40. Tatemichi TK, Desmond DW, Paik M, et al. Clinical determinants of dementia related to stroke. Ann Neurol. 1993; 33:568-575.
41. Pohjasvaara T, Erkinjuntti T, Ylikoski R, et al. Clinical determinants of poststroke dementia. Stroke. 1998;29:75-81.
42. Chen X, Wen W, Anstey KJ, et al. Prevalence, incidence, and risk factors of lacunar infarcts in a community sample. Neurology. 2009;73:266-272.
43. Chui HC. Vascular cognitive impairment: Today and tomorrow. Alzheimers Dement. 2006;2:185-194.
44. Swartz RH, Black SW. Anteriori-medial thalamic lesions in dementia: Frequent, and volume dependently associated with sudden cognitive decline. J Neurol Neurosurg Psychiatry. 2006; 77:1307-1312.
45. Mendez MF, Cummings JL. Dementia. A Clinical Approach. 3rd ed. Philadelphia: Elsevier Science Publishing Company; 2003.
46. Fisher CM. Lacunes: Small, deep cerebral infarcts. Neurology. 1965;15:774-784.
47. Yue NC, Arnold AM, Longstreth WT Jr, et al. Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: Data from the cardiovascular health study. Radiology. 1997;202:33-39.
48. Zhu YC, Tzourio C, Soumaré A, et al. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: A populationbased study. Stroke. 2010;41:2483-2490.
49. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318-1322.
50. Awad IA, Johnson PC, Spetzler RF, et al. Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations. Stroke. 1986;17:1090-1097.
51. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: A review. Stroke. 1997;28:652-659.
52. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: An anatomic study. Am J Neuroradiol. 1990;11:431-439.
53. Black S, Gao F, Bilbao J. Understanding white matter disease: Pathological correlations in vascular cognitive impairment. Stroke. 2009;40:S48-S52.
54. Wen W, Sachdev P. The topography of white matter hyperintensities on brain MRI in healthy 60-to 64-year old individuals. Neuroimage. 2004;22:144-154.
55. Wen W, Sachdev P, Li JJ, et al. White matter hyperintensities in the forties: Their prevalence and topography in an epidemiological sample aged 44-48. Hum Brain Mapp. 2009; 30:1155-1167.
56. Erkinjuntti T, Ketonen L, Sulkava R, et al. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 1987;50:37-42.
57. Price CC, Jefferson AL, Merino JG, et al. Subcortical vascular dementia: Integrating neuropsychological and neuroradiologic data. Neurology. 2005;65:376-382.
58. DeCarli C, Murphy DG, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology. 1995;45:2077-2084.
59. Brown WR, Moody DM, Thore CR, et al. Vascular dementia in leukoaraiosis may be a consequence of capillary loss not only in the lesions, but in normal-appearing white matter and cortex as well. J Neurol Sci. 2007;257:62-66.
60. Nitkunan A, Barrick TR, Charlton RA, et al. Multimodal MRI in cerebral small vessel disease: Its relationship with cognition and sensitivity to change over time. Stroke. 2008;39: 1999-2005.
61. Starkstein SE, Jorge R, Capizzano AA. Uncommon causes of cerebrovascular dementia. Int Psychogeriatr. 2005;17:S51-S64.
62. Hunt WE. Clinical assessment of SAH. J Neurosurg. 1983; 59:550-551.
63. Ishikawa E, Yanaka K, Sugimoto K, et al. Reversible dementia in patients with chronic subdural hematomas. J Neurosurg. 2002;96:680-683.
64. Attems J, Jellinger K, Thal DR, et al. Review: Sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2011;37:75-93.
65. Yamamoto Y, Craggs L, Baumann M, et al. Molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol. 2011;37:94-113.
66. Werring DJ, Gregoire SM, Cipolotti L. Cerebral microbleeds and vascular cognitive impairment. J Neurol Sci. 2010;299: 131-135.
67. Goos JD, Kester MI, Barkhof F, et al. Patients with Alzheimer disease with multiple microbleeds: Relation with cerebrospinal fluid biomarkers and cognition. Stroke. 2009;40:3455-3460.
68. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: Systematic review, subgroup analyses and standards for study design and reporting. Brain. 2007; 130:1988-2003.
69. Merino JG, Warach S. Imaging of acute stroke. Nat Rev Neurol. 2010;6:560-571.
70. Nour M, Liebeskind DS. Brain imaging in stroke: Insight beyond diagnosis. Neurotherapeutics. 2011;8:330-339.
71. Tartaglia MC, Rosen HJ, Miller BL. Neuroimaging in dementia. Neurotherapeutics. 2011;8:82-92.
72. Lee JH, Kim Sh, Kim GH, et al. Identification of pure subcortical vascular dementia using 11C-Pittsburgh compound B. Neurology. 2011;77:18-25.
73. Mok V, Leung EY, Chu W, et al. Pittsburgh compound B binding in poststroke dementia. J Neurol Sci. 2010;290: 135-137.
74. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol. 2004;3:184-190.
75. Hendrie HC, Albert MS, Butters MA, et al. The NIH cognitive and emotional health project. Report of the Critical Evaluation Study Committee. Alzheimer Dement. 2006;2:12-32.
76. Purnell C, Gao S, Callahan CM, et al. Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature. Alzheimer Dis Assoc Disord. 2009;23:1-10.
77. Deramecourt V, Slade JY, Oakley AE, et al. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 2012;78:1043-1050.
78. Roman GC. Senile dementia of the Binswangeer type: A vascular from of dementia in the elderly. JAMA. 1987;258: 1782-1788.
79. Carrera E, Bogousslavsky J. The thalamus and behavior: Effects of anatomically distinct strokes. Neurology. 2006;66: 1817-1823.
80. Neuropathology Group of the Medical Research Council Cognitive Function, and Aging Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001;357:169-175.
81. Toledo JB, Arnold SE, Raible K, et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain. 2013;136:2697-2706.
82. Gold G, Giannakopoulos P, Herrmann FR, et al. Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain. 2007;130:2830-2836.
83. Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: How to move forward? Neurology. 2009;72: 368-374.
84. Jeste DV, Meeks TW, Kim DS, et al. Research agenda for DSM-V: Diagnostic categories and criteria for neuropsychiatric syndromes in dementia. J Geriatr Psychiatry Neurol. 2006;19: 160-171.